Last reviewed · How we verify
Momordica Charantia Extract
Momordica Charantia Extract is a Small molecule drug developed by Syamsudin Abdillah,Ph.D, Pharm D. It is currently in Phase 2 development. Also known as: 2nd group.
At a glance
| Generic name | Momordica Charantia Extract |
|---|---|
| Also known as | 2nd group |
| Sponsor | Syamsudin Abdillah,Ph.D, Pharm D |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Combination of Bitter Melon Extract and Snakehead Fish Powder to Reduce Glycaemia in Type 2 Diabetes Mellitus (NA)
- Combined Bitter Melon Extract and Snakehead Fish Powder Supplementation for Glycemic Control in Type 2 Diabetes (NA)
- Effects of Milk Probiotics Intervention on Blood Glucose Control Middle-aged and Elderly People With Pre-diabetes (NA)
- Effect of Using Bitter Melon, Blueberries and Cranberries on HbA1c and Diabetes Symptom Levels (NA)
- Effect of a Dietary Supplement on Hormones Involved in Appetite Regulation in Overweight and Obese Adults (NA)
- Evaluation of Effects of Dibifree® on Regulation of Blood Sugar and HbA1c in Patients With Type II Diabetes (NA)
- Explore the Effect of Bitter Melon Peptides on Glycemic Control and Metabolic Indicators in Diabetic Patients (NA)
- Effects of Milk Powder Intervention on Blood Glucose Control and Fluctuation in Middle-aged and Elderly People With Pre-diabetes (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Momordica Charantia Extract CI brief — competitive landscape report
- Momordica Charantia Extract updates RSS · CI watch RSS
- Syamsudin Abdillah,Ph.D, Pharm D portfolio CI
Frequently asked questions about Momordica Charantia Extract
What is Momordica Charantia Extract?
Momordica Charantia Extract is a Small molecule drug developed by Syamsudin Abdillah,Ph.D, Pharm D.
Who makes Momordica Charantia Extract?
Momordica Charantia Extract is developed by Syamsudin Abdillah,Ph.D, Pharm D (see full Syamsudin Abdillah,Ph.D, Pharm D pipeline at /company/syamsudin-abdillah-ph-d-pharm-d).
Is Momordica Charantia Extract also known as anything else?
Momordica Charantia Extract is also known as 2nd group.
What development phase is Momordica Charantia Extract in?
Momordica Charantia Extract is in Phase 2.
Related
- Manufacturer: Syamsudin Abdillah,Ph.D, Pharm D — full pipeline
- Also known as: 2nd group
- Compare: Momordica Charantia Extract vs similar drugs
- Pricing: Momordica Charantia Extract cost, discount & access